Achieve rapid, accurate results with the Nicolet iS50 FT-IR spectrometer, which automates instrument setup and optimizes workflows for diverse analytical needs.
AZoM on MSN
Industrial Applications of FTIR Spectroscopy
Advances in FTIR instrumentation support quantitative industrial analysis.
Thermo Fisher Scientific is reiterated as a 'buy' with a fair value estimate of $619 per share, reflecting confidence in its recovery and strategic positioning. TMO's acquisition of Clario Holdings ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted ...
Waltham, Massachusetts-based Thermo Fisher Scientific Inc. (TMO) provides life sciences solutions, analytical instruments, specialty diagnostics, laboratory products, and biopharma services. It is ...
Thermo Fisher Scientific will close its Franklin facility between late 2026 and late 2027. The closure of the biologics storage and cell therapy plant will result in the loss of 103 jobs. The action ...
Thermo Fisher Scientific is launching a new test it says can help doctors avoid the “trial-and-error” approach typically used to dose patients with a common antirejection drug after organ transplant ...
Boston Scientific grew sales and adjusted earnings per share by 16% and 14% in the fourth quarter. However, the company's guidance underwhelmed the market. Ultimately, Boston Scientific's earnings ...
Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance that slightly fell short of elevated investor expectations. This response was ...
Different analytical methods have a significant impact on the results of scientific studies. This is demonstrated by a study conducted by an international research team. In the study, more than 300 ...
Boston Scientific (BSX) lost ~9% in the premarket on Wednesday after the MedTech giant indicated an underwhelming outlook for 2026 with its Q4 2025 results, which, however, beat Street forecasts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results